Acadia Pharmaceuticals Inc. (ACAD)

Health Care·equity

$19.78

+1.02% today

Extended hours $19.96

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

44/ 100

Score level

Average

6 of 6 checks had data

Business numbers are one of its highest-scoring factors; score for how it compares with the broader market is near the bottom of its range.

ACAD scores higher than 57% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Acadia Pharmaceuticals Inc. (ACAD) scores 44 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.70× 30-day average
52-week range: 19.32 – 30.96
Market cap: $4.70B
Earnings date: 3 Nov 2026

Volume: 1,470,141
Avg. volume (30d): 2,089,005

Open: 19.60
Previous close: 19.58
Day's range (regular session): 19.58 – 20.05

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 0.90
P/E (TTM): 8.90
EPS (TTM): 2.21

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for ACAD

8 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for ACAD. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about ACAD right now

Acadia Pharmaceuticals Inc. (ACAD) currently scores 44/100 on the Market Census six-factor composite, at the Average score level. ACAD is +1.02% on the day and -1.38% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in ACAD's data roughly balance out right now. ACAD's strongest factor is company finances at 94/100 — a very strong read on the company's own reported numbers. A high reading doesn't promise a near-term move. The weakest factor is strength vs the market at 26/100 — below average next to the wider market.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See ACAD in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score